Multiple Sclerosis or Fabry Disease – Pros and Cons by Iris Zavoreo, Miljenka-Jelena Jurašić, Marijana Lisak, Ana Jadrijević Tomas, Vanja Bašić Kes

Subjects: Get full text

Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations by Verónica Cabreira, Pedro Abreu, Ricardo Soares-dos-Reis, Joana Guimarães, Maria José Sá

Subjects: Get full text

A Case Report of Vasculitis Necrotizing after Interferon beta-1b Injection in Multiple Sclerosis by Mehrdokht Mazdeh

Subjects: Get full text

Quality of Care for Patients With Multiple Sclerosis—A Review of Existing Quality Indicators by Anna Kristina Kraft, Klaus Berger

Subjects: Get full text

Innovative Therapies Redefine Treatment Goals in Multiple Sclerosis by Ines Lazibat, Radenka Kuzmanić Šamija, Krešimir Rotim

Subjects: “…Multiple sclerosis – therapy…”
Get full text

Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis by Liesa Regner-Nelke, Marc Pawlitzki, Alice Willison, Leoni Rolfes, Sinem-Hilal Oezalp, Christopher Nelke, Tristan Kölsche, Melanie Korsen, Matthias Grothe, Sergiu Groppa, Felix Luessi, Sinah Engel, Gereon Nelles, Eckhard Bonmann, Holger Roick, Anke Friedrich, Philipp Knorn, Harald Landefeld, Zoltan Biro, Michael Ernst, Antonios Bayas, Martina Menacher, Katja Akgün, Christoph Kleinschnitz, Tobias Ruck, Tjalf Ziemssen, Refik Pul, Sven G. Meuth

Subjects: Get full text